Search Results - "Ehinger, Yann"
-
1
Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice
Published in Nature communications (27-07-2021)“…Alcohol Use Disorder (AUD) affects a large portion of the population. Unfortunately, efficacious medications to treat the disease are limited. Studies in…”
Get full text
Journal Article -
2
Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome
Published in Neurobiology of disease (01-02-2021)“…Rett syndrome (RTT) is a severe X-linked neurodevelopmental disorder that is primarily caused by mutations in the methyl CpG binding protein 2 gene (MECP2)…”
Get full text
Journal Article -
3
mTORC1 in the orbitofrontal cortex promotes habitual alcohol seeking
Published in eLife (11-12-2019)“…The mechanistic target of rapamycin complex 1 (mTORC1) plays an important role in dendritic translation and in learning and memory. We previously showed that…”
Get full text
Journal Article -
4
cAMP-Fyn signaling in the dorsomedial striatum direct pathway drives excessive alcohol use
Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2021)“…Fyn kinase in the dorsomedial striatum (DMS) of rodents plays a central role in mechanisms underlying excessive alcohol intake. The DMS is comprised of medium…”
Get full text
Journal Article -
5
Correction: mTORC1 in the orbitofrontal cortex promotes habitual alcohol seeking
Published in eLife (04-05-2022)Get full text
Journal Article -
6
A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome
Published in Neurobiology of disease (01-03-2017)“…Abstract Rett syndrome (RTT) is a severe X-linked neurodevelopmental disorder that is primarily caused by mutations in the methyl CpG binding protein 2 gene (…”
Get full text
Journal Article -
7
Rett syndrome from bench to bedside: recent advances [version 1; peer review: 2 approved]
Published in F1000 research (2018)“…Rett Syndrome is a severe neurological disorder mainly due to de novo mutations in the methyl-CpG-binding protein 2 gene ( MECP2). Mecp2 is known to play a…”
Get full text
Journal Article -
8
Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome
Published in International journal of molecular sciences (21-04-2021)“…Mutations in the X-linked gene are responsible for Rett syndrome (RTT), a severe neurological disorder. MECP2 is a transcriptional modulator that finely…”
Get full text
Journal Article -
9
Huntingtin phosphorylation governs BDNF homeostasis and improves the phenotype of Mecp2 knockout mice
Published in EMBO molecular medicine (07-02-2020)“…Mutations in the X‐linked MECP2 gene are responsible for Rett syndrome (RTT), a severe neurological disorder for which there is no treatment. Several studies…”
Get full text
Journal Article -
10
Ultrasound-Mediated Blood-Brain Barrier Opening Improves Whole Brain Gene Delivery in Mice
Published in Pharmaceutics (12-08-2021)“…Gene therapy represents a powerful therapeutic tool to treat diseased tissues and provide a durable and effective correction. The central nervous system (CNS)…”
Get full text
Journal Article -
11
PI3-Kinase p110β in Cortical Circuitries and Cocaine-Dependent Maladaptative Behaviors
Published in Biological psychiatry (1969) (15-05-2021)Get full text
Journal Article -
12
PI3-Kinase p110β in Cortical Circuitries and Cocaine-Dependent Maladaptive Behaviors
Published in Biological psychiatry (1969) (15-05-2021)Get full text
Journal Article -
13
State‐of‐the‐art therapies for Rett syndrome
Published in Developmental medicine and child neurology (01-02-2023)“…Rett syndrome (RTT) is an X‐linked neurogenetic disorder caused by mutations of the MECP2 (methyl‐CpG‐binding protein 2) gene. Over two decades of work…”
Get full text
Journal Article -
14
A non-hallucinogenic psychedelic analogue with therapeutic potential
Published in Nature (London) (21-01-2021)“…The psychedelic alkaloid ibogaine has anti-addictive properties in both humans and animals 1 . Unlike most medications for the treatment of substance use…”
Get full text
Journal Article -
15
The Small G-Protein Rac1 Promotes Neuroadaptations that Underlie Alcohol Use Disorder
Published in Alcohol (Fayetteville, N.Y.) (01-06-2023)Get full text
Journal Article -
16
Identification of Novel BDNF-Specific Corticostriatal Circuitries
Published in eNeuro (01-05-2023)“…Brain-derived neurotrophic factor (BDNF) is released from axon terminals originating in the cerebral cortex onto striatal neurons. Here, we characterized BDNF…”
Get full text
Journal Article -
17
The BDNF Val68Met polymorphism causes a sex specific alcohol preference over social interaction and also acute tolerance to the anxiolytic effects of alcohol, a phenotype driven by malfunction of BDNF in the ventral hippocampus of male mice
Published in Psychopharmacology (01-02-2023)“…Background The brain-derived neurotrophic factor (BDNF) Valine 66 to Methionine human polymorphism results in impaired activity-dependent BDNF release and has…”
Get full text
Journal Article -
18
Differential correlation of serum BDNF and microRNA content in rats with rapid or late onset of heavy alcohol use
Published in Addiction biology (01-03-2021)“…Heavy alcohol use reduces the levels of the brain‐derived neurotrophic factor (BDNF) in the prefrontal cortex of rodents through the upregulation of microRNAs…”
Get full text
Journal Article Web Resource